Information:
Fel:
ID
29397
Beskrivning
Study part: Subset PK Sample Informed Consent Screening. A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus.
Nyckelord
Versioner (1)
- 2018-03-21 2018-03-21 -
Rättsinnehavare
Roche
Uppladdad den
21 mars 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Subset PK Sample Informed Consent Screening Ranibizumab Macular Edema Diabetes Mellitus FVF4170g
Subset PK Sample Informed Consent Screening
- StudyEvent: ODM
Similar models
Subset PK Sample Informed Consent Screening
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Subset PK Sample Informed Consent Screening
C0201734 (UMLS CUI-1)
C0370003 (UMLS CUI-2)
C0370003 (UMLS CUI-2)
Subject number
Item
Subject number:
text
C2348585 (UMLS CUI [1])
Subject initials
Item
Subject initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
C2986440 (UMLS CUI [1,2])
Visit date
Item
Visit date:
date
C1320303 (UMLS CUI [1])
Study Subject Participation Status
Item
Not Applicable (Subject not participating)
boolean
C2348568 (UMLS CUI [1])
Informed Consent Date
Item
Date subject signed research sample informed consent:
date
C2985782 (UMLS CUI [1])